NEW YORK (GenomeWeb News) — Affymetrix has licensed several of its microarray-related patents to Empire Genomics, Affy said today.
Under the non-exclusive agreement, Empire Genomics, a Buffalo, NY-based molecular diagnostics company, will use Affy’s technology to manufacture, use, and sell DNA chips and related products and services for comparative genomic hybridization, Affy said.
Financial terms of the agreement were not released.